激活大麻素2型 (CB2) 受体可以改善鱼类,Brycon amazonicus中的心脏收缩性能
Yan Costa Gonçalves1, Karina Carla de Francisco Campos2, Eliton da Silva Vasconcelos2
1Department of Physiological Sciences, Federal University of São Carlos (UFSCar), 13565-905 São Carlos, São Paulo, Brazil; Joint Graduate Program in Physiological Sciences, Federal University of São Carlos (UFSCar)/São Paulo State University (UNESP), 13565-905 São Carlos, São Paulo, Brazil.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
|December 19, 2023
概括
在鱼心中激活大麻素受体2 (CB2) 通过增强处理和激发-收缩合,改善了心脏功能. 这表明CB2受体是心脏收缩功能障碍的潜在治疗标.
科学领域:
- 心血管生理学心血管生理学
- 药理学 药理学是指药理学的学科.
- 内类大麻素系统研究研究
背景情况:
- 大麻素受体 (CB1和CB2) 在心血管功能中具有复杂的作用,关于它们的具体作用仍在争论中.
- 内激素系统为心血管疾病提供了潜在的治疗途径,但受体特异性的作用需要澄清.
研究的目的:
- 研究CB1+CB2或CB2激动剂对心脏刺激-收缩 (E-C) 合的影响.
- 使用鱼类模型确定CB2受体在调节心脏表现中的特定作用.
主要方法:
- 利用来自鱼类 (Brycon amazonicus) 的隔离室内心肌.
- 使用CB1+CB2或CB2激动剂来评估对心脏功能的影响.
- 测量周期性腺3',5'-单酸盐 (cAMP) 生产和关键处理蛋白 (SERCA,NCX).
主要成果:
- 服用CB2激动剂导致显著的正面无otropic和luzitropic效应.
- CB2激活导致cAMP的产生增加.
- 观察到关键的Ca2+处理蛋白的升级,包括SERCA和NCX.
结论:
- CB2受体激活通过改善循环和激发-收缩合效率来提高心脏性能.
- CB2受体是治疗心脏收缩功能障碍的一个有希望的治疗标.
相关概念视频
Pathophysiology of Cardiac Performance
672
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
672
Antihypertensive Drugs: Action of Calcium Channel Blockers
526
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
526
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
526
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
526


